Robert Howard Goldstein, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Drug Approval | 2 | 2020 | 740 | 0.920 |
Why?
|
| Anti-HIV Agents | 6 | 2021 | 4250 | 0.880 |
Why?
|
| Alanine | 2 | 2020 | 572 | 0.790 |
Why?
|
| Adenosine Monophosphate | 1 | 2020 | 276 | 0.660 |
Why?
|
| HIV Infections | 10 | 2021 | 16678 | 0.510 |
Why?
|
| Carcinoma, Merkel Cell | 1 | 2019 | 299 | 0.500 |
Why?
|
| Adenine | 1 | 2019 | 936 | 0.480 |
Why?
|
| HIV-1 | 2 | 2021 | 6934 | 0.420 |
Why?
|
| Bone Neoplasms | 4 | 2011 | 2522 | 0.390 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 2019 | 2231 | 0.360 |
Why?
|
| Sex Factors | 2 | 2019 | 10392 | 0.330 |
Why?
|
| Antiviral Agents | 1 | 2020 | 2978 | 0.320 |
Why?
|
| Clinical Trials as Topic | 2 | 2019 | 7901 | 0.290 |
Why?
|
| Homosexuality, Male | 4 | 2020 | 1238 | 0.290 |
Why?
|
| Blood Donors | 2 | 2017 | 355 | 0.250 |
Why?
|
| Antibodies, Monoclonal | 1 | 2020 | 9274 | 0.230 |
Why?
|
| Carcinoma, Ductal, Breast | 1 | 2010 | 1101 | 0.220 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2019 | 4029 | 0.220 |
Why?
|
| Smallpox Vaccine | 1 | 2022 | 80 | 0.210 |
Why?
|
| Virus Shedding | 1 | 2022 | 108 | 0.200 |
Why?
|
| HIV-2 | 1 | 2021 | 167 | 0.190 |
Why?
|
| Mesenchymal Stem Cells | 1 | 2010 | 1625 | 0.180 |
Why?
|
| Pharyngitis | 1 | 2021 | 215 | 0.180 |
Why?
|
| Confusion | 1 | 2021 | 275 | 0.170 |
Why?
|
| Skin Neoplasms | 1 | 2019 | 5662 | 0.170 |
Why?
|
| Lymphopenia | 1 | 2021 | 285 | 0.170 |
Why?
|
| Exanthema | 1 | 2023 | 488 | 0.170 |
Why?
|
| Physician Assistants | 1 | 2020 | 193 | 0.160 |
Why?
|
| Breast Neoplasms | 5 | 2011 | 20774 | 0.150 |
Why?
|
| Myositis | 1 | 2019 | 251 | 0.140 |
Why?
|
| Fever | 2 | 2021 | 1612 | 0.140 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2021 | 2557 | 0.130 |
Why?
|
| HIV Antibodies | 1 | 2021 | 1320 | 0.120 |
Why?
|
| Disease Models, Animal | 2 | 2011 | 18006 | 0.120 |
Why?
|
| Drug Combinations | 1 | 2019 | 1961 | 0.120 |
Why?
|
| Prejudice | 1 | 2018 | 569 | 0.120 |
Why?
|
| Virus Replication | 1 | 2022 | 2531 | 0.120 |
Why?
|
| Glomerulosclerosis, Focal Segmental | 1 | 2017 | 359 | 0.120 |
Why?
|
| Deglutition Disorders | 1 | 2019 | 604 | 0.110 |
Why?
|
| Diagnosis, Differential | 4 | 2021 | 12958 | 0.110 |
Why?
|
| Viral Load | 1 | 2021 | 3292 | 0.110 |
Why?
|
| United States Food and Drug Administration | 1 | 2019 | 1581 | 0.100 |
Why?
|
| Epstein-Barr Virus Infections | 1 | 2017 | 569 | 0.100 |
Why?
|
| Receptors, Interleukin-17 | 1 | 2010 | 69 | 0.090 |
Why?
|
| United States | 6 | 2021 | 69693 | 0.090 |
Why?
|
| Public Health | 1 | 2022 | 2594 | 0.090 |
Why?
|
| Humans | 23 | 2023 | 742088 | 0.090 |
Why?
|
| rho-Associated Kinases | 1 | 2009 | 279 | 0.080 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2011 | 520 | 0.080 |
Why?
|
| Melanoma, Experimental | 1 | 2011 | 559 | 0.080 |
Why?
|
| Female | 12 | 2022 | 379592 | 0.080 |
Why?
|
| Autoimmune Diseases | 1 | 2019 | 2130 | 0.070 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2010 | 4751 | 0.070 |
Why?
|
| Mice, Inbred NOD | 1 | 2010 | 1875 | 0.070 |
Why?
|
| Gene Transfer Techniques | 1 | 2011 | 1224 | 0.070 |
Why?
|
| Lymph Nodes | 1 | 2017 | 3465 | 0.070 |
Why?
|
| Mice, SCID | 1 | 2010 | 2715 | 0.060 |
Why?
|
| Stromal Cells | 1 | 2010 | 1353 | 0.060 |
Why?
|
| Interleukin-17 | 1 | 2010 | 900 | 0.060 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2019 | 3239 | 0.060 |
Why?
|
| Muscle, Skeletal | 1 | 2019 | 4933 | 0.060 |
Why?
|
| Cell Communication | 1 | 2010 | 1619 | 0.060 |
Why?
|
| Bone Marrow Cells | 1 | 2010 | 2513 | 0.050 |
Why?
|
| Transforming Growth Factor beta | 1 | 2010 | 2006 | 0.050 |
Why?
|
| Drug Discovery | 1 | 2011 | 1057 | 0.050 |
Why?
|
| Injections, Intradermal | 1 | 2022 | 117 | 0.050 |
Why?
|
| Monkeypox virus | 1 | 2022 | 48 | 0.050 |
Why?
|
| Smallpox | 1 | 2022 | 45 | 0.050 |
Why?
|
| Transplantation, Heterologous | 1 | 2010 | 2382 | 0.050 |
Why?
|
| Physicians | 1 | 2020 | 4554 | 0.050 |
Why?
|
| Neoplasm Invasiveness | 1 | 2009 | 3612 | 0.050 |
Why?
|
| Kidney | 1 | 2017 | 7167 | 0.050 |
Why?
|
| Students | 2 | 2021 | 1647 | 0.050 |
Why?
|
| Pandemics | 1 | 2020 | 8328 | 0.050 |
Why?
|
| Male | 9 | 2023 | 349538 | 0.050 |
Why?
|
| Vaccination | 2 | 2022 | 3256 | 0.040 |
Why?
|
| Myoglobinuria | 1 | 2019 | 23 | 0.040 |
Why?
|
| Health Occupations | 1 | 2021 | 223 | 0.040 |
Why?
|
| Rhabdomyolysis | 1 | 2019 | 150 | 0.040 |
Why?
|
| Gene Expression Profiling | 2 | 2010 | 9410 | 0.040 |
Why?
|
| Cell Line, Tumor | 2 | 2011 | 16665 | 0.040 |
Why?
|
| Blood Safety | 1 | 2016 | 14 | 0.040 |
Why?
|
| Carotid Artery, Internal | 1 | 2019 | 445 | 0.040 |
Why?
|
| Mice | 4 | 2011 | 81045 | 0.040 |
Why?
|
| Muscle Weakness | 1 | 2019 | 414 | 0.030 |
Why?
|
| Ventriculoperitoneal Shunt | 1 | 2017 | 194 | 0.030 |
Why?
|
| Health Knowledge, Attitudes, Practice | 2 | 2021 | 3915 | 0.030 |
Why?
|
| Urinalysis | 1 | 2017 | 369 | 0.030 |
Why?
|
| Brain | 1 | 2021 | 26343 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2021 | 35342 | 0.030 |
Why?
|
| Cerebral Infarction | 1 | 2019 | 1007 | 0.030 |
Why?
|
| Nephrotic Syndrome | 1 | 2017 | 389 | 0.030 |
Why?
|
| Animals | 5 | 2011 | 168561 | 0.030 |
Why?
|
| Middle Aged | 3 | 2022 | 213127 | 0.030 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2019 | 1440 | 0.030 |
Why?
|
| Government Regulation | 1 | 2016 | 522 | 0.030 |
Why?
|
| Herpesvirus 4, Human | 1 | 2017 | 1040 | 0.030 |
Why?
|
| Silk | 1 | 2011 | 87 | 0.020 |
Why?
|
| Hydrocephalus | 1 | 2017 | 746 | 0.020 |
Why?
|
| Radiography, Thoracic | 1 | 2017 | 1265 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2019 | 20086 | 0.020 |
Why?
|
| Headache | 1 | 2017 | 1219 | 0.020 |
Why?
|
| Cross-Sectional Studies | 2 | 2021 | 24913 | 0.020 |
Why?
|
| History, 20th Century | 1 | 2016 | 2739 | 0.020 |
Why?
|
| Health Personnel | 1 | 2022 | 3210 | 0.020 |
Why?
|
| Lymphoma | 1 | 2017 | 1873 | 0.020 |
Why?
|
| Protein Engineering | 1 | 2011 | 541 | 0.020 |
Why?
|
| Sexual Behavior | 1 | 2017 | 2050 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2009 | 23387 | 0.020 |
Why?
|
| Plasmids | 1 | 2011 | 2305 | 0.020 |
Why?
|
| Kidney Diseases | 1 | 2017 | 2145 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2009 | 987 | 0.010 |
Why?
|
| Primary Health Care | 1 | 2020 | 4551 | 0.010 |
Why?
|
| Ultrasonography | 1 | 2017 | 5978 | 0.010 |
Why?
|
| Incidence | 1 | 2022 | 20928 | 0.010 |
Why?
|
| Transfection | 1 | 2011 | 5892 | 0.010 |
Why?
|
| Adult | 3 | 2023 | 213712 | 0.010 |
Why?
|
| Breast | 1 | 2011 | 1958 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2009 | 5180 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2009 | 3920 | 0.010 |
Why?
|
| RNA, Small Interfering | 1 | 2009 | 3504 | 0.010 |
Why?
|
| Bone and Bones | 1 | 2011 | 2575 | 0.010 |
Why?
|
| Time Factors | 1 | 2022 | 40054 | 0.010 |
Why?
|
| Nanoparticles | 1 | 2011 | 1902 | 0.010 |
Why?
|
| Neoplasm Metastasis | 1 | 2009 | 4839 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2009 | 5975 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 2009 | 3800 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2022 | 53187 | 0.010 |
Why?
|
| Cell Movement | 1 | 2009 | 5212 | 0.010 |
Why?
|
| Gene Expression | 1 | 2009 | 7790 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2009 | 13029 | 0.010 |
Why?
|
| MicroRNAs | 1 | 2009 | 3731 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 2011 | 13655 | 0.000 |
Why?
|
| Aged | 1 | 2019 | 162944 | 0.000 |
Why?
|